News of Editorial: HRD minister Shri Prakash Javadekar presented Most Outstanding Researcher Award to Prof Ashok Pandey ; Dr. Sunil Kaul and Dr. Renu Wadhwa were awarded “AIST President Award” ON April 2
News in Focus: Professor Balram Bhargava
appointed DG of ICMR; Dr. Renu Swarup appointed as Secretary of Department of Biotechnology
Editorial: Probiotics and Products
Startup Story:Shreeji Biotech’s Skill Development Training Program on Microbiological Techniques
April 18, 2018 | By Biotech Express News Bureau || The Union health ministry has proposed to amend Drugs and Cosmetics Act that may finally bring stem cells and cell-based products under the ambit of the law. In a notification issued on April 4, the ministry defined the category of stem cells and their derivatives that would be termed a drug, and would thereby have to follow the protocols mandated for any drug development.